Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Enlivex Therapeutics Ltd. (ENLV)

  • Business News
  • Jan. 23, 2026, 13:00 UTC
  • 0
  • 1 comments

Enlivex Therapeutics Shares to Trade Exclusively on Nasdaq

Market reaction Comment Full text

Daxor Corporation (DXR)

  • Business News
  • Jan. 23, 2026, 13:00 UTC
  • 0
  • 1 comments

Daxor Corporation Announces $9 Million Registered Direct Offering

Market reaction Comment Full text

Bausch Health Companies Inc (BHC)

  • Business News
  • Jan. 23, 2026, 12:47 UTC
  • 0
  • 1 comments

Bausch Health Notification

Market reaction Comment Full text

Bausch Health Companies Inc (BHC)

  • Business News
  • Jan. 23, 2026, 12:45 UTC
  • 0
  • 1 comments

Bausch Health Provides Update on RED-C Phase 3 Clinical Trials

Market reaction Comment Full text

Sanara Medtech Inc (SMTI)

  • Business News
  • Jan. 23, 2026, 12:30 UTC
  • 0
  • 1 comments

Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance

Market reaction Comment Full text

Apollo Medical Holdings Inc (AMN)

  • Business News
  • Jan. 23, 2026, 12:30 UTC
  • 0
  • 1 comments

AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026

Market reaction Comment Full text

Canopy Growth Corp (CGC)

  • Business News
  • Jan. 23, 2026, 12:03 UTC
  • 0
  • 1 comments

Canopy Growth Communication - Canopy Growth to Report Third Quarter Fiscal 2026 Financial Results on February 6, 2026

Market reaction Comment Full text

Medtronic plc. (MDT)

  • Business News
  • Jan. 23, 2026, 12:02 UTC
  • 0
  • 1 comments

Affera™ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360™ PFA catheter to treat paroxysmal atrial fibrillation

Market reaction Comment Full text

OKYO Pharma (OKYO)

  • Business News
  • Jan. 23, 2026, 12:00 UTC
  • 0
  • 1 comments

FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain

Market reaction Comment Full text

Eledon Pharmaceuticals Inc. (ELDN)

  • Business News
  • Jan. 23, 2026, 12:00 UTC
  • 0
  • 1 comments

Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium

Market reaction Comment Full text
  • Previous
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next

Search

News categories

  • Technical Exchange News(10839)
  • Event(2204)
  • SEC News(187788)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124243)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin